Cambridge, MA
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.
centessa.comThese are collections Centessa Pharmaceuticals is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$225,000,000
Post Ipo Equity
$100,000,000
Post Ipo Debt
$300,000,000
Series A
$250,000,000
IPO
Unknown
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Centessa Pharmaceuticals.